Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA)

NCT02247375 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: Low dose of BIIL 284 BS tablets
DRUG: High dose of BIIL 284 BS tablets
DRUG: Placebo

Sponsor

Boehringer Ingelheim